Eric Lefkofsky’s Digital Approach to Cancer Treatment

Cancer is one of the leading killer diseases in the World. It manifests itself in different forms. With over 200 types of cancer, its treatment is expensive, considering the many Chemotherapy sessions a patient has to undergo. Challenges facing treatment include late screening, lack of specialized machines and inaccurate diagnosis. Eric Lefkofsky, an entrepreneur, based in Chicago, is advancing the treatment of cancer through the use of technology.

On-target Treatment

Eric is the co-founder of Tempus. A technology company that focuses on attaining precision medication for cancer patients. They do this by collecting bio-data of cancer patients. These data include diagnosis and treatment history. They then make these data available for other cancer doctors worldwide. Their main aim is to enable cancer specialists to use these data to make an informed decision.

Comparison

Tempus Labs makes it easier for cancer doctors to compare molecular data among patients. Doctors can get data of old cancer patients and compare it with that of the new patient. This helps them make an informed decision on the type of treatment to administer.

Eric Lefkofsky

Apart from co-founding Tempus Labs, Eric ixs also the co-founder of other giant tech firms. They include Uptake Technologies and Echo Global Logistics, among others. Also, he is the co-founder of Lightbank which deals with Disruptive Technologies. He has had a stint as a lecturer teaching disruptive business models. Additionally, he is the author of the book “Accelerated Disruption.”

Foundation

Eric Lefkofsky has a charitable foundation which he started with his wife. Lefkofsky Family Foundation provides funds to initiatives that create a positive impact on people. He is also a trustee for the Chicago’s Lurie hospital for children and The Museum of Science and Industry, among others.

In Summary, he is one of the most iconic entrepreneurs in America who is creating a significant impact on technology. Tempus Labs is revolutionizing the treatment of cancer. It also advances the use of technology in medicine.